Related Experiment Video

Updated: Jul 13, 2026

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

[Different methods of myocardial revascularization in non-stable stenocardia]

I V Zakharov, K S Deĭneka, G A Gazarian

    Klinicheskaia Meditsina
    |August 2, 2007
    PubMed

    Insights

    Percutaneous coronary intervention is often the best choice for myocardial revascularization. Coronary bypass surgery with cardiopulmonary bypass is preferred for left coronary artery stenosis with left ventricular dysfunction.

    Area of Science:

    • Cardiovascular Surgery
    • Interventional Cardiology

    Background:

    • Evaluating myocardial revascularization strategies is crucial for managing non-stable stenocardia.
    • Comparison of percutaneous coronary intervention (PCCI) and coronary bypass surgery (CBS) with or without cardiopulmonary bypass (CPB) is essential.

    Observation:

    • 322 patients with non-stable stenocardia were analyzed.
    • Group 1 (n=226) had mono-, bi-, or tri-vascular lesions, undergoing PCCI or CBS without CPB.
    • Group 2 (n=96) had tri-vascular lesions, undergoing CBS with or without CPB.

    Findings:

    • PCCI is the preferred method for most patients, including those with tri-vascular lesions.
    • CBS without CPB is suitable for extensive isolated stenosis of the anterior descending coronary artery with chronic occlusions.
    • CBS with CPB is indicated for left coronary artery trunk stenosis and left ventricular dysfunction.

    Implications:

    • PCCI offers a versatile approach for myocardial revascularization.
    • Tailoring surgical strategy based on coronary artery lesion complexity and ventricular function is key.
    • CBS without CPB may be insufficient for complete revascularization in specific complex cases.

    Related Concept Videos

    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...